GSK-2793660 is an irreversible, orally bioavailable Cathepsin C (CTSC) inhibitor. This dipeptidyl compound has been investigated in preclinical studies for bronchiectasis, where it demonstrated activity in reducing neutrophil serine protease activity in relevant in vitro and in vivo models.
Molekulargewicht:
357.45
CAS Nummer:
[1613458-70-0]
Formel:
C20H27N3O3
Target-Kategorie:
Others,Cysteine Protease
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten